These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
309 related items for PubMed ID: 29371591
1. MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALS. Shvil N, Banerjee V, Zoltsman G, Shani T, Kahn J, Abu-Hamad S, Papo N, Engel S, Bernhagen J, Israelson A. Cell Death Dis; 2018 Jan 25; 9(2):107. PubMed ID: 29371591 [Abstract] [Full Text] [Related]
2. Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS. Leyton-Jaimes MF, Benaim C, Abu-Hamad S, Kahn J, Guetta A, Bucala R, Israelson A. Proc Natl Acad Sci U S A; 2016 Sep 06; 113(36):10198-203. PubMed ID: 27551074 [Abstract] [Full Text] [Related]
3. MIF homolog d-dopachrome tautomerase (D-DT/MIF-2) does not inhibit accumulation and toxicity of misfolded SOD1. Alaskarov A, Barel S, Bakavayev S, Kahn J, Israelson A. Sci Rep; 2022 Jun 10; 12(1):9570. PubMed ID: 35688953 [Abstract] [Full Text] [Related]
4. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS. Leyton-Jaimes MF, Kahn J, Israelson A. Proc Natl Acad Sci U S A; 2019 Jul 16; 116(29):14755-14760. PubMed ID: 31262807 [Abstract] [Full Text] [Related]
6. Targeting low levels of MIF expression as a potential therapeutic strategy for ALS. Alfahel L, Gschwendtberger T, Kozareva V, Dumas L, Gibbs R, Kertser A, Baruch K, Zaccai S, Kahn J, Thau-Habermann N, Eggenschwiler R, Sterneckert J, Hermann A, Sundararaman N, Vaibhav V, Van Eyk JE, Rafuse VF, Fraenkel E, Cantz T, Petri S, Israelson A. Cell Rep Med; 2024 May 21; 5(5):101546. PubMed ID: 38703766 [Abstract] [Full Text] [Related]
7. Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1. Israelson A, Ditsworth D, Sun S, Song S, Liang J, Hruska-Plochan M, McAlonis-Downes M, Abu-Hamad S, Zoltsman G, Shani T, Maldonado M, Bui A, Navarro M, Zhou H, Marsala M, Kaspar BK, Da Cruz S, Cleveland DW. Neuron; 2015 Apr 08; 86(1):218-32. PubMed ID: 25801706 [Abstract] [Full Text] [Related]
8. The molecular tweezer CLR01 inhibits aberrant superoxide dismutase 1 (SOD1) self-assembly in vitro and in the G93A-SOD1 mouse model of ALS. Malik R, Meng H, Wongkongkathep P, Corrales CI, Sepanj N, Atlasi RS, Klärner FG, Schrader T, Spencer MJ, Loo JA, Wiedau M, Bitan G. J Biol Chem; 2019 Mar 08; 294(10):3501-3513. PubMed ID: 30602569 [Abstract] [Full Text] [Related]
9. Nonnative SOD1 trimer is toxic to motor neurons in a model of amyotrophic lateral sclerosis. Proctor EA, Fee L, Tao Y, Redler RL, Fay JM, Zhang Y, Lv Z, Mercer IP, Deshmukh M, Lyubchenko YL, Dokholyan NV. Proc Natl Acad Sci U S A; 2016 Jan 19; 113(3):614-9. PubMed ID: 26719414 [Abstract] [Full Text] [Related]
15. A computational combinatorial approach identifies a protein inhibitor of superoxide dismutase 1 misfolding, aggregation, and cytotoxicity. Banerjee V, Oren O, Ben-Zeev E, Taube R, Engel S, Papo N. J Biol Chem; 2017 Sep 22; 292(38):15777-15788. PubMed ID: 28768772 [Abstract] [Full Text] [Related]
16. A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis. Maier M, Welt T, Wirth F, Montrasio F, Preisig D, McAfoose J, Vieira FG, Kulic L, Späni C, Stehle T, Perrin S, Weber M, Hock C, Nitsch RM, Grimm J. Sci Transl Med; 2018 Dec 05; 10(470):. PubMed ID: 30518612 [Abstract] [Full Text] [Related]
17. Nuclear export of misfolded SOD1 mediated by a normally buried NES-like sequence reduces proteotoxicity in the nucleus. Zhong Y, Wang J, Henderson MJ, Yang P, Hagen BM, Siddique T, Vogel BE, Deng HX, Fang S. Elife; 2017 May 02; 6():. PubMed ID: 28463106 [Abstract] [Full Text] [Related]
18. Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form. Kerman A, Liu HN, Croul S, Bilbao J, Rogaeva E, Zinman L, Robertson J, Chakrabartty A. Acta Neuropathol; 2010 Mar 02; 119(3):335-44. PubMed ID: 20111867 [Abstract] [Full Text] [Related]
19. New links between SOD1 and metabolic dysfunction from a yeast model of amyotrophic lateral sclerosis. Bastow EL, Peswani AR, Tarrant DS, Pentland DR, Chen X, Morgan A, Staniforth GL, Tullet JM, Rowe ML, Howard MJ, Tuite MF, Gourlay CW. J Cell Sci; 2016 Nov 01; 129(21):4118-4129. PubMed ID: 27656112 [Abstract] [Full Text] [Related]
20. Intercellular Prion-Like Conversion and Transmission of Cu/Zn Superoxide Dismutase (SOD1) in Cell Culture. Grad LI, Pokrishevsky E, Cashman NR. Methods Mol Biol; 2017 Nov 01; 1658():357-367. PubMed ID: 28861801 [Abstract] [Full Text] [Related] Page: [Next] [New Search]